Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Salvatore Corallo

Researcher

University of Pavia

Italy

Research Interests

Explore related searches

Professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (13)

Fabian Finkelmeier

University Hospital Frankfurt

GERMANY

View details

David J. Pinato

Imperial College London

UNITED KINGDOM

View details

Hong Jae Chon

Associate Professor

CHA Bundang Medical Center

SOUTH KOREA

View details

Barbara Oliviero

Researcher

Fondazione IRCCS Policlinico San Matteo

ITALY

View details

ilhwan kim

Associate Professor

Inje University Ilsan Paik Hospital

SOUTH KOREA

View details

Jin Won Kim

Professor

Seoul National University Hospital

SOUTH KOREA

View details

Giovanni Farinea

University of Turin

ITALY

View details

Andrea Casadei-Gardini

Ospedale San Raffaele

ITALY

View details

Lorenzo Antonuzzo

University of Florence

ITALY

View details

Lorenza Rimassa

Head of Hepatopancreatobiliary Oncology Unit

Humanitas University

ITALY

View details

Riziero Esposito Abate

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Maria Tieri

European Institute of Oncology

ITALY

View details

Rossana Berardi

Associate Professor

Università Politecnica delle Marche

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Salvatore Corallo

Research Interests

Explore related searches

Articles (20)

Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy

Development, Expansion, and Histological Characterization of Patient-Derived Liver Organoids for Drug Screening and Disease Modeling.

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study

Conversion strategies in RAS wild-type colorectal liver metastases: a systematic review and meta-analysis of first-line trials comparing regimens with anti-epidermal growth factor receptor inhibitors versus bevacizumab

Fruquintinib or Regorafenib? A Weighted Toxicity Score Analysis to Facilitate Better Discussions on Toxicity and Benefits in Later-line Colorectal Cancer Treatment

Visceral-to-subcutaneous fat ratio is a time-stable predictor of survival and toxicity in advanced hepatocellular carcinoma

Digital Nutritional Care in Oncology: Opportunities to Enhance Quality of Life and Support Patient-Centered Care

Durvalumab–Tremelimumab in Advanced Hepatocellular Carcinoma: Real‐World Data From the <scp>LOR</scp> ‐ <scp>HCC</scp> (Lombardy Real‐World <scp>HCC</scp> Group)

Thyroid toxicity in lung cancer patients treated with immune-checkpoint inhibitors: a single-center retrospective analysis

Anti-EGFR plus chemotherapy vs. chemotherapy alone in RAS wild-type colorectal liver metastases: A meta-analysis of survival outcomes in resectable and unresectable settings

Germline Findings From Tumor-Only Comprehensive Genomic Profiling in the RATIONAL Study: A Missed Opportunity?

Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab.

A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC‐D Index

Nutritional Support via Jejunostomy Placed During Staging Laparoscopy for Esophagogastric Cancer: A Case Series

Case Report: Epstein-Barr virus negative lymphoepithelioma-like cholangiocarcinoma: a rare tumor that deserves further exploration. Report of a case with distinct genomic and clinical features

The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine and durvalumab: a large real-life worldwide population

HER2, HER3 and mismatch repair protein expression in stage IV small bowel adenocarcinoma: results from a multicenter series

Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real‐world results from a multicenter and multinational study

<i>BRCA2</i>-Related Hereditary Cancer Syndrome-Associated Small Bowel Adenocarcinoma With Multiple <i>BRCA2</i> Mutations: A Case Report and Review of the Literature

Adenomyoma/adenomyomatosis-associated mural intracholecystic neoplasms: analysis of clinico-pathologic, imaging, and molecular features of a consecutive case series

Collaborators (13)

Fabian Finkelmeier

David J. Pinato

Hong Jae Chon

Barbara Oliviero

ilhwan kim

Jin Won Kim

Giovanni Farinea

Andrea Casadei-Gardini

Lorenzo Antonuzzo

Lorenza Rimassa

Riziero Esposito Abate

Maria Tieri

Rossana Berardi

Make your next move.